We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+7.01%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$235M
AUM Growth
+$14.9M
Cap. Flow
+$1.25M
Cap. Flow %
0.53%
Top 10 Hldgs %
44.28%
Holding
75
New
5
Increased
32
Reduced
21
Closed
2

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$645K
2
DHR icon
Danaher
DHR
+$497K
3
ADI icon
Analog Devices
ADI
+$405K
4
ABT icon
Abbott
ABT
+$273K
5
WFC icon
Wells Fargo
WFC
+$214K

Sector Composition

Rank Sector Weight
1 Healthcare 23.92%
2 Technology 18.42%
3 Consumer Staples 14.77%
4 Industrials 9.67%
5 Consumer Discretionary 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLB icon
51
Core Laboratories
CLB
$488M
$574K 0.24%
4,950
+600
+14% +$69.7K
MSFT icon
52
Microsoft
MSFT
$3.45T
$550K 0.23%
8,329
+468
+6% +$30K
XOM icon
53
ExxonMobil
XOM
$644B
$543K 0.23%
6,628
+578
+10% +$48.3K
CSCO icon
54
Cisco
CSCO
$457B
$494K 0.21%
14,534
+34
+0.2% +$1.1K
BIIB icon
55
Biogen
BIIB
$30B
$487K 0.21%
1,785
+5
+0.3% +$1.41K
KHC icon
56
Kraft Heinz
KHC
$30.7B
$445K 0.19%
4,887
+1,362
+39% +$123K
ESRX
57
DELISTED
Express Scripts Holding Company
ESRX
$445K 0.19%
6,735
+355
+6% +$24.4K
ADI icon
58
Analog Devices
ADI
$179B
$423K 0.18%
+5,163
New +$405K
T icon
59
AT&T
T
$159B
$393K 0.17%
12,403
+4,805
+63% +$151K
GPC icon
60
Genuine Parts
GPC
$17.1B
$391K 0.17%
4,255
CMA
61
DELISTED
Comerica
CMA
$356K 0.15%
5,157
HAIN icon
62
Hain Celestial
HAIN
$45M
$311K 0.13%
8,405
-13,020
-61% -$490K
ETN icon
63
Eaton
ETN
$161B
$285K 0.12%
3,856
IBM icon
64
IBM
IBM
$211B
$278K 0.12%
1,674
EMR icon
65
Emerson Electric
EMR
$83.9B
$243K 0.1%
4,057
MO icon
66
Altria Group
MO
$114B
$235K 0.1%
3,307
BMY icon
67
Bristol-Myers Squibb
BMY
$133B
$228K 0.1%
4,225
+275
+7% +$15.1K
VZ icon
68
Verizon
VZ
$195B
$216K 0.09%
4,414
WFC icon
69
Wells Fargo
WFC
$261B
$211K 0.09%
+3,775
New +$214K
HON icon
70
Honeywell
HON
$77B
$208K 0.09%
+1,843
New +$204K
MRK icon
71
Merck
MRK
$322B
$206K 0.09%
+3,370
New +$204K
TGT icon
72
Target
TGT
$65.6B
$202K 0.09%
3,675
GCVRZ
73
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$5K ﹤0.01%
10,660
VSM
74
DELISTED
Versum Materials, Inc.
VSM
-7,150
Closed -$200K
LLTC
75
DELISTED
Linear Technology Corp
LLTC
-24,545
Closed -$1.52M

Similar funds

Dillon & Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Dillon & Associates held 75 positions worth $235M, up 6.8% from $220M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Dillon & Associates's Q1 2017 filing shows 5 new, 32 increased, 21 reduced and 2 closed positions. Its largest new stake was JPMorgan Chase: 7,310 shares worth $643K. The largest sale was Linear Technology Corp, an estimated $1.52M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Staples.

  • Dillon & Associates's largest Q1 2017 buy was JPMorgan Chase: 7,310 shares worth $643K.
  • Dillon & Associates added most to Danaher in Q1 2017, an estimated $497K increase.
  • Dillon & Associates's biggest Q1 2017 reduction was Hain Celestial, cutting an estimated $490K.
  • Dillon & Associates fully exited Linear Technology Corp in Q1 2017, selling an estimated $1.52M.
  • Dillon & Associates's ten largest holdings make up 44% of its $235M portfolio in Q1 2017.
  • Dillon & Associates opened 5 new positions and closed 2 in Q1 2017.
  • Dillon & Associates's portfolio value rose 6.8% quarter-over-quarter to $235M.

Based on Dillon & Associates's 13F filing for Q1 2017, filed 26 Apr 2017.